Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 513

1.

[Concurrent concentrated radio-chemotherapy of epidermoid cancer of the esophagus. Long-term results of a phase II national multicenter trial in 122 non-operable patients (FFCD 8803)].

Seitz JF, Milan C, Giovannini M, Dumas F, Cauvin JM, Conroy T, François E, Renard P, Votte-Lambert A, Paillot B, Bedenne L; Fondation Française de Cancérologie Digestive; Groupe Digestif de la Fédération Nationale des Centres de Lutte Contre le Cancer.

Gastroenterol Clin Biol. 2000 Feb;24(2):201-10. French.

PMID:
12687962
2.

[Cisplatin, 5-FU and preoperative radiotherapy in esophageal epidermoid cancer. Multicenter phase II FFCD 8804 study].

Bedenne L, Seitz JF, Milan C, Renard P, Fraisse J, Conroy T, Lacourt J, Janoray P, Faivre J.

Gastroenterol Clin Biol. 1998 Mar;22(3):273-81. French.

3.

[Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].

Farzad M, De Luca MC, Rubino G, Pirtoli L, Pepi F, Sebaste L, Ponticelli P, Atzeni G, Maranzano E, Silvano G.

Radiol Med. 2001 Jul-Aug;102(1-2):72-7. Italian.

PMID:
11677442
4.
5.

Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancer.

Kleinberg L, Knisely JP, Heitmiller R, Zahurak M, Salem R, Burtness B, Heath EI, Forastiere AA.

Int J Radiat Oncol Biol Phys. 2003 Jun 1;56(2):328-34.

PMID:
12738305
6.

[The combined radiochemotherapy of inoperable esophageal neoplasms: a feasibility study].

Sola B, Airoldi M, Orecchia R, Rovea P, Fracchia F, Boidi Trotti A, Tessa M, Foco A, Oliaro A, Casadio C, Dei Poli M.

Radiol Med. 1996 Apr;91(4):456-9. Italian.

PMID:
8643859
7.

Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.

Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM).

Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. Epub 2006 Jan 18.

PMID:
16414206
8.

Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.

Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J Jr, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):427-36.

PMID:
15380576
9.

Influence of hemoglobin levels on survival after radical treatment of esophageal carcinoma with radiotherapy.

Valencia Julve J, Alonso Orduña V, Escó Barón R, López-Mata M, Méndez Villamón A.

Clin Transl Oncol. 2006 Jan;8(1):22-30.

PMID:
16632436
10.
11.
12.

Concomitant chemotherapy and external radiotherapy plus brachytherapy for locally advanced esophageal cancer: results of a retrospective multicenter study.

Tessa M, Rotta P, Ragona R, Sola B, Grassini M, Nassisi D, Sciacero P, Airoldi M, Filippi A, Gianello L, De Angelis C, Ozzello F, Trotti AB, Ricardi U, Sannazzari GL.

Tumori. 2005 Sep-Oct;91(5):406-14.

PMID:
16459637
13.

Inoperable nonmetastatic squamous cell carcinoma of the esophagus managed by concomitant chemotherapy (5-fluorouracil and cisplatin) and radiation therapy.

Seitz JF, Giovannini M, Padaut-Cesana J, Fuentes P, Giudicelli R, Gauthier AP, Carcassonne Y.

Cancer. 1990 Jul 15;66(2):214-9.

14.

Ten-year survival with chemotherapy and radiotherapy in patients with squamous cell carcinoma of the esophagus.

Bidoli P, Bajetta E, Stani SC, De CD, Santoro A, Valente M, Zucali R, Valagussa P, Ravasi G, Bonadonna G.

Cancer. 2002 Jan 15;94(2):352-61.

15.

Preoperative concomitant radiochemotherapy in squamous cell carcinoma of the esophagus: results of a study of 56 patients.

Malhaire JP, Labat JP, Lozac'h P, Simon H, Lucas B, Topart P, Volant A.

Int J Radiat Oncol Biol Phys. 1996 Jan 15;34(2):429-37. Review.

PMID:
8567345
16.
17.

[Concomitant radiochemotherapy in inoperable non-small cell lung cancer].

Hennequin C, Trédaniel J, Durdux C, Salemkour A, Zalcman G, Hirsch A, Housset M, Maylin C.

Cancer Radiother. 1997;1(2):143-7. French.

PMID:
9273185
18.

[Role of an exclusive concomitant radio-chemotherapy treatment in non operable esophageal cancer: results of a 10-year experience in Antoine-Lacassagne Center].

Magné N, François E, Touati L, Marcy PY, Van Houtte P, Lagrange JL.

Bull Cancer. 2005 Feb;92(2):184-90. French.

19.

Long-term outcome of mitomycin C- and 5-FU-based primary radiochemotherapy for esophageal cancer.

Wolf M, Zehentmayr F, Niyazi M, Ganswindt U, Haimerl W, Schmidt M, Hölzel D, Belka C.

Strahlenther Onkol. 2010 Jul;186(7):374-81. doi: 10.1007/s00066-010-2137-y. Epub 2010 Jun 24.

PMID:
20582393
20.

Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.

Choi N, Park SD, Lynch T, Wright C, Ancukiewicz M, Wain J, Donahue D, Mathisen D.

Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):111-22.

PMID:
15337546

Supplemental Content

Support Center